Evidence map›Paper›PMID 37038301›Full record

SynthesisBrain and behavior2023

Seeking safety intervention for comorbid post-traumatic stress and substance use disorder: A meta-analysis.

Athena D F Sherman, Monique Balthazar, Wenhui Zhang, Sarah Febres-Cordero, Kristen D Clark, Meredith Klepper, Mercy Coleman, Ursula Kelly

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Brain and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Athena D F ShermanThe Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.ORCID 0000-0002-3652-1196
Monique BalthazarThe Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Wenhui ZhangThe Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.ORCID 0000-0001-9328-2315
Sarah Febres-CorderoThe Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Kristen D ClarkSchool of Nursing, University of California San Francisco, San Francisco, California.
Meredith KlepperJohns Hopkins University School of Nursing, Johns Hopkins University, Baltimore, Maryland.
Mercy ColemanByrdine F. Lewis College of Nursing and Health Professions, Georgia State University, Atlanta, Georgia.
Ursula KellyThe Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Emory University · USGeorgia State University · USJohns Hopkins University · USUniversity of California, San Francisco · US

Funding

A Behavioral Intervention to Reduce Psychological Distress Symptoms among Black Gender Minority Women Experiencing Chronic StigmaK23NR020208 · NINR · EMORY UNIVERSITY · PI SHERMAN, ATHENA D. F. · 2022 to 2024
$487k
NINR NIH HHS K23 NR020208
6 · The paper itself

Abstract

problem statementSeeking Safety (SS) is a widely implemented cognitive-behavioral therapy for comorbid post-traumatic stress disorder (PTSD) and substance use disorder (SUD). It is a present-focused coping skills model that is highly flexible, with varied methods of delivery, to maximize acceptability and client access. The purpose of this meta-analysis is to examine the effect of SS on comorbid PTSD and SUD across randomized control trials (RCTs). In addition, ours is the first meta-analysis to examine the dose-response of SS by comparing delivery of all 25 SS topics versus fewer. METHODS AND

designArticles published before January 2, 2023 (CINAHL n = 16, PsycINFO n = 31, MEDLINE n = 27, Cochrane n = 38, and Scopus n = 618) were searched. Seven studies were included for meta-analysis and dose-response analysis.

resultsBased on effect sizes (ES), meta-analysis revealed that SS has a medium group, time (p = .04), and time by group effect on substance use per the Addiction Severity Index at 3 months and a small effect on Clinician-Administered PTSD Scale scores by group, a large effect by time, and a medium time by group (p = .002) effect at 6 months. Based on the pooled ES examining various measures across multiple timepoints, SS had small to medium effects on substance use by time, group, or time by group and medium to large effects on PTSD symptoms by time, group, or time by group (except for the group effect at 3-month follow-up). Significant effects were found for substance use by time at 3 and 6 months and for PTSD postintervention, at 6 months and 9 months by group, time, and time by group while only by time at 3 months. Meta-regression revealed that partial dose versions of SS generally function as well as the full dose version of SS when observing long-term effects (greater than 3 months). DISCUSSION: Findings suggest SS has merit in treating PTSD symptoms and SUD. Based on the summarized effect sizes, SS appears more effective in reducing PTSD than substance use, which converges with the larger treatment outcome literature that consistently finds this. We explore reasons that treatment of SUD is more challenging than treating PTSD and offer suggestions for practitioners. We emphasize the need for future studies to utilize common measures and provide full details of treatment delivery for optimal comparison across studies.

Indexed as

Cognitive Behavioral TherapyStress Disorders, Post-TraumaticSubstance-Related DisordersAdaptation, PsychologicalComorbidityHumansTreatment Outcomebehavioral therapycopingmental healthPTSD

Identifiers

PMID37038301
PMCPMC10175993
OpenAlexW4364353331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.